• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

H19内胚层增强子是实验性肝癌发生过程中Igf2激活和肿瘤形成所必需的。

The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis.

作者信息

Vernucci M, Cerrato F, Besnard N, Casola S, Pedone P V, Bruni C B, Riccio A

机构信息

Centro di Endocrinologia ed Oncologia Sperimentale 'G Salvatore', CNR; Dipartimento di Biologia e Patologia Cellulare e Molecolare 'L Califano', Università di Napoli 'Federico II', Napoli, Italy.

出版信息

Oncogene. 2000 Dec 14;19(54):6376-85. doi: 10.1038/sj.onc.1204024.

DOI:10.1038/sj.onc.1204024
PMID:11175353
Abstract

The expression of the linked but reciprocally imprinted Igf2 and H19 genes is activated in adult liver in the course of tumor development. By in situ hybridization analysis we have shown that both the Igf2 and H19 RNAs are expressed in the majority of the neoplastic nodules, and that hepatocellular carcinomas are developed in an experimental model of liver carcinogenesis. H19 is also highly activated in smaller and less distinct hyperplastic regions. The few neoplastic areas showing Igf2 but no H19 RNA display loss of the maternally inherited allele at the Igf2/H19 locus. These data are compatible with the existence of a common activation mechanism of these two genes during liver carcinogenesis and with a stronger H19 induction in the pre-neoplastic lesions. By using mice carrying a deletion of the H19 endodermal enhancer, we show that this regulatory element is necessary for the activation of the Igf2 and H19 genes upon induction of liver carcinogenesis. Furthermore, multiple sites of the H19 endodermal enhancer region become hypersensitive to DNase I when the carcinogenesis process is induced. Lastly, liver tumors developed in mice paternally inheriting the H19 enhancer deletion are found to have marked growth delays, increased frequency of apoptotic nuclei, and lack of Igf2 mRNA expression, thus indicating that this regulatory element plays a major role in the progression of liver carcinogenesis, since it is required for the activation of the anti-apoptotic Igf2 gene.

摘要

在肿瘤发生过程中,连锁但相互印记的Igf2和H19基因的表达在成年肝脏中被激活。通过原位杂交分析,我们发现Igf2和H19 RNA在大多数肿瘤结节中均有表达,并且在肝癌发生的实验模型中出现了肝细胞癌。H19在较小且不太明显的增生区域也被高度激活。少数显示Igf2但无H19 RNA的肿瘤区域在Igf2/H19位点表现出母系遗传等位基因的缺失。这些数据与这两个基因在肝癌发生过程中存在共同激活机制以及在癌前病变中H19诱导更强相一致。通过使用携带H19内胚层增强子缺失的小鼠,我们表明该调控元件对于肝癌发生诱导时Igf2和H19基因的激活是必需的。此外,当诱导致癌过程时,H19内胚层增强子区域的多个位点对DNase I变得高度敏感。最后,在父系遗传H19增强子缺失的小鼠中发生的肝肿瘤被发现具有明显的生长延迟、凋亡核频率增加以及缺乏Igf2 mRNA表达,因此表明该调控元件在肝癌发生进展中起主要作用,因为它是抗凋亡Igf2基因激活所必需的。

相似文献

1
The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis.H19内胚层增强子是实验性肝癌发生过程中Igf2激活和肿瘤形成所必需的。
Oncogene. 2000 Dec 14;19(54):6376-85. doi: 10.1038/sj.onc.1204024.
2
Regulatory mechanisms at the mouse Igf2/H19 locus.小鼠Igf2/H19基因座的调控机制。
Mol Cell Biol. 2001 Dec;21(23):8189-96. doi: 10.1128/MCB.21.23.8189-8196.2001.
3
Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19.Igf2中沉默子元件的缺失导致印记丢失,且与H19无关。
Nat Genet. 2000 Oct;26(2):203-6. doi: 10.1038/79930.
4
Role of H19 3' sequences in controlling H19 and Igf2 imprinting and expression.H19 3'序列在控制H19和Igf2印记及表达中的作用。
Genomics. 2004 Jul;84(1):59-68. doi: 10.1016/j.ygeno.2003.12.001.
5
An enhancer element at the Igf2/H19 locus drives gene expression in both imprinted and non-imprinted tissues.Igf2/H19基因座处的增强子元件在印记组织和非印记组织中均驱动基因表达。
Dev Biol. 2004 Jul 15;271(2):488-97. doi: 10.1016/j.ydbio.2004.04.022.
6
Developmentally regulated functions of the H19 differentially methylated domain.H19差异甲基化区域的发育调控功能。
Hum Mol Genet. 2004 Feb 1;13(3):353-61. doi: 10.1093/hmg/ddh028. Epub 2003 Dec 17.
7
Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.大鼠H19基因上游区域在发育和转基因肝癌发生过程中的DNA甲基化谱变化及其在H19基因印记转录调控中的作用。
Mol Carcinog. 2004 Sep;41(1):1-16. doi: 10.1002/mc.20036.
8
CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.CCCTC结合因子(CTCF)介导H19/胰岛素样生长因子2(Igf2)基因座处的甲基化敏感增强子阻断活性。
Nature. 2000 May 25;405(6785):486-9. doi: 10.1038/35013106.
9
An enhancer deletion affects both H19 and Igf2 expression.增强子缺失会影响H19和Igf2的表达。
Genes Dev. 1995 Sep 1;9(17):2079-89. doi: 10.1101/gad.9.17.2079.
10
H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19.H19和Igf2单等位基因表达通过H19上游一个共享的顺式作用调控区域以两种不同方式受到调控。
Genes Dev. 2000 May 15;14(10):1186-95.

引用本文的文献

1
The role of autophagy in cardiovascular disease: Cross-interference of signaling pathways and underlying therapeutic targets.自噬在心血管疾病中的作用:信号通路的交叉干扰及潜在治疗靶点
Front Cardiovasc Med. 2023 Mar 29;10:1088575. doi: 10.3389/fcvm.2023.1088575. eCollection 2023.
2
The Role of Autophagy in Liver Cancer: Crosstalk in Signaling Pathways and Potential Therapeutic Targets.自噬在肝癌中的作用:信号通路中的相互作用及潜在治疗靶点
Pharmaceuticals (Basel). 2020 Nov 28;13(12):432. doi: 10.3390/ph13120432.
3
Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis.
非编码RNA:甲状腺癌发病机制中未知的调节因子
Cancers (Basel). 2020 Nov 4;12(11):3264. doi: 10.3390/cancers12113264.
4
Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma.长链非编码RNA在肝细胞癌中扮演关键角色。
Biomark Cancer. 2017 Nov 2;9:1179299X17737301. doi: 10.1177/1179299X17737301. eCollection 2017.
5
Prohibitin 1 Regulates the H19-Igf2 Axis and Proliferation in Hepatocytes.抑制素1调节肝细胞中的H19-IGF2轴及增殖。
J Biol Chem. 2016 Nov 11;291(46):24148-24159. doi: 10.1074/jbc.M116.744045. Epub 2016 Sep 29.
6
Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism.肝细胞癌中的长链非编码RNA:对其机制的新见解
World J Hepatol. 2015 Dec 8;7(28):2781-91. doi: 10.4254/wjh.v7.i28.2781.
7
The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.尼莫样激酶(NLK)在癌症调控中的新作用。
Tumour Biol. 2015 Dec;36(12):9147-52. doi: 10.1007/s13277-015-4159-7. Epub 2015 Oct 1.
8
Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets.发育与癌症中的长链非编码RNA:潜在的生物标志物与治疗靶点。
Mol Cell Ther. 2015 Jun 12;3:5. doi: 10.1186/s40591-015-0042-6. eCollection 2015.
9
Differential reactivation of fetal/neonatal genes in mouse liver tumors induced in cirrhotic and non-cirrhotic conditions.肝硬化和非肝硬化条件下诱导的小鼠肝肿瘤中胎儿/新生儿基因的差异激活
Cancer Sci. 2015 Aug;106(8):972-81. doi: 10.1111/cas.12700. Epub 2015 Jun 25.
10
Anti-insulin-like growth factor-IIP3 DNAzymes inhibit cell proliferation and induce caspase-dependent apoptosis in human hepatocarcinoma cell lines.抗胰岛素样生长因子-IIP3脱氧核酶抑制人肝癌细胞系的细胞增殖并诱导半胱天冬酶依赖性凋亡。
Drug Des Devel Ther. 2013 Oct 4;7:1089-102. doi: 10.2147/DDDT.S48971. eCollection 2013.